BOTULINUM NEUROTOXIN A IMMUNE FAB2 / BOTULINUM NEUROTOXIN B IMMUNE FAB2 / BOTULINUM NEUROTOXIN C IMMUNE FAB2 / BOTULINUM NEUROTOXIN D IMMUNE FAB2 / BOTULINUM NEUROTOXIN E IMMUNE FAB2 / BOTULINUM NEUROTOXIN F IMMUNE FAB2 / BOTULINUM NEUROTOXIN G IMMUNE FAB2 Injection

Category(s)
other
SPL Type(s)
Plasma Derivative
Master SPL
Cangene Corporation (2015-09-01)
Oldest Current Product
2013-03-01
License(s)
BLA
RxNORM
INJECTION\BOTULINUM NEUROTOXIN A IMMUNE FAB2:BOTULINUM NEUROTOXIN B IMMUNE FAB2:BOTULINUM NEUROTOXIN C IMMUNE FAB2:BOTULINUM NEUROTOXIN D IMMUNE FAB2:BOTULINUM NEUROTOXIN E IMMUNE FAB2:BOTULINUM NEUROTOXIN F IMMUNE FAB2:BOTULINUM NEUROTOXIN G IMMUNE FAB2
SPL Active
INTRAVENOUS\LIQUID\EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
SPL Moiety
INTRAVENOUS\LIQUID\EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2: EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2

product(s) by strength(s)

botulinum neurotoxin a immune fab2, equine 4500 unt / botulinum neurotoxin b immune fab2, equine 3300 unt / botulinum neurotoxin c immune fab2, equine 3000 unt / botulinum neurotoxin d immune fab2, equine 600 unt / botulinum neurotoxin e immune fab2, equine 5100 unt / botulinum neurotoxin f immune fab2, equine 3000 unt / botulinum neurotoxin g immune fab2, equine 600 unt injection

original product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1604920075BLACangene Corporation2013-03-01EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2INTRAVENOUSLIQUID1254629f3c4292-8773-4781-8264-d71c80d3eabd

application(s)

#idtitleapprovedtradenamesfda division
1125462Botulism Antitoxin Heptavalent (A B C D E F G) - (Equine) Application2013-03-22BATCBER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
19f3c4292-8773-4781-8264-d71c80d3eabd (view SPL)These highlights do not include all the information needed to use BAT safely and effectively. See full prescribing information for BAT.BAT, [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)]Sterile Solution for InjectionInitial U.S. Approval: 2013otherPlasma DerivativeCangene CorporationMANUFACTURE2015-09-011604920075

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII